Published in Pharma Law Weekly, December 2nd, 2008
"We are gratified by the extremely positive response Interceptas has received in the marketplace. We've won more major customers in the last year than any competitor and our growth continues to gain momentum as Internet merchants realize the value of Accertify's comprehensive, integrated approach to fighting fraud," said Jeff Liesendahl, CEO of Accertify.
Industry leaders in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2008-12-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.